Clinical trial
Clinical Efficacy and Safety of Perampanel Monotherapy in the Treatment of Children With Focal Epilepsy
NCT05497193 is registered in ClinicalTrials.gov with Yang Xinwei as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Clinical Efficacy and Safety of Perampanel Monotherapy in the Treatment of Children With Focal Epilepsy
- Lead sponsor
- Yang Xinwei
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- July 1, 2021
- Completion date
- October 20, 2023
- Enrollment
- 280 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
focal epilepsy